furious

k d Joined Jun 20, 2013

I'm new, but learning something everyday. I like bios/ tech, but they must have fundamentals. Read everything you can. P.S. If you try to pick the bottom every time, all you get is sticky fingers. P.P.S Use stops.

Following

  1. Thumb-1402585770
    barna
    Barna
    28 year old full time trader specializing in BioPharm. Bearish or bulish, just dont be foolish. #LGR.
  2. Thumb-1361659530
    IPOTrader
    John Noland
  3. Thumb-1398524326
    upsidetrader
    joe donohue Official Account
    Full time trader. On Wall St. for over twenty years. Founder long/short hedge fund. Currently manages private accounts and with a long/short strategy. To request my performance, e-mail me at upsidetrader@gmail.com
  4. Thumb-1352902831
    BVHealthcare
    BV Healthcare
  5. Thumb-1384400908
    JasonMD
    JasonMD
    19 years of experience and practices in Internal Medicine and Gastroenterology. Investor in small cap biotechs.
  6. Thumb-1367025606
    BioDueDiligence
    Andrew G.
    Professional scientific skeptic and biotech/pharma commentator. Founder / editor of BiotechDueDiligence and Clinical Oncology Targets
  7. Thumb-1326594905
    EXPstocktrader
    EXPstocktrader
  8. Thumb-1409036915
    Keynesonomics
    Keynesonomics
    Penn State Econ major~Scholar of Behavioral Finance & 30yr mkt trader~Proponent of the notion that psychology & emotion recurrently contest the efficient market hypothesis*DISCLAIMER:NEVER trade any security based on my opinions~Live Life~Smile Often
  9. Thumb-1390480259
    micheleciani
    Michele Ciani
    Expert stocks trader, trading on technical charts, in-depth studies, analysis and rumors. Focus on Small cap Biotech and new emerging Healthcare company.
  10. Thumb-1362074089
    ACE52WeekHigh
    AceMoneyPicks
    Day, swing, momentum, and value trader. A combination of technical, fundamentals, & contrarian trading. Macro Economics
  11. Thumb-1389705208
    PowerTriggerTrade
    Sandro
    Developer of the Power Pattern lines system that minimizes false signals and maximizes strong entry signals. Witness premium picks with a strong focus on top notch accuracy. I only will respond to my followers
  12. Thumb-1407351960
    DaytradeWarrior
    Ross Cameron
    Daytrade Warrior is a community of professional daytraders working together to generate ideas, post breaking news, and educate beginner traders. I run a live audio/screenshare feed into my office so anyone that wants to watch me trading can stop by
  13. Thumb-1373126630
    Finch_31
    Jason Fisch
    Stats as of 2012 :: Portfolio: +9.08% w/ 15 Open Positions (4 Years) // 20 Wins / 29 Trades (69%) // Best Trade: +146.22% // Avg Win: 19.75% // Avg Loss: -24.48% [Follow Portfolio & Disclaimer @ www.StocksNBiz.com]
  14. Thumb-1399764694
    Talib_Gunther
    Talib Gunther
    Full time private trader. Masters degree from University of Washington. World traveler, writer, and researcher / Abundance is a state of mind / Wealth is the ability to share / The best way to predict the future is to create it
  15. Thumb-1341968079
    RalfKaiser
    Ralf Kaiser
    ♦ Aficionado of Optimal Trading Strategies in Stocks, ETFs, ES Futures and Forex ♦ Incorporating effective strategies in to high performing portfolios ♦ Husband to ONE; Father to THREE ♦
  16. Thumb-1355781853
  17. Thumb-1357779087
    Catalyst_Funk
    Vincent
    Biotechs mostly, Swing+Pos'n Trader. Diversify,Risk Mgmt,Technicals+Fundamentals/valuation. I'm also on Twitter. *Disclaimer: Your investment/trading decisions are solely your own responsibility.AlwaysDoYourOwnDD.* HappyTrading!
  18. Thumb-1402078204
    AlgoSniffer
    Gonzo Chinaski
    $BIB $BIS Trade Sheet - Free Field Test - Link Below
  19. Thumb-1366329606
    AceOfSpades
    Andrew Colburn
    First year trading 280% growth -- 2012 (biotechs). ~35% growth in my Dad's IRA (Jun-Dec2012).
  20. Thumb-1405279587
    russdorff
    Russell Deardorff
    ( Barge Captain) U.S. Merchant Marine, 32 years. Amateur investor since 97, intrigued with Bio-Tech stocks since 2/12, after doubling investment with VIVUS phase III data